Friday 6 November 2026 Export LQDA’s income statement to Excel — free account

Liquidia Corporation

LQDA Healthcare Drug Manufacturers Specialty & Generic

Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.

Revenue: +1,842.7%
EPS: +271.4%
Free cash flow: +270.2%
Total debt: −9.04%

Quarter to June 2026, against a year earlier

44.69 2.69 −5.68%

Follow LQDA

Alert me

Market cap: $4.0B
P/E: 28.5×
Fwd P/E: 22.1×
Dividend yield: —
F-score: 5/9
Altman Z: 4.08
Beneish M: 6.79
Dividend safety: n/a

Overview

Liquidia Corporation (LQDA) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Liquidia Corporation (LQDA) trades at a P/E ratio of 28.5×. Over the past ten years it has ranged from 0.0× (March 2026) to 326× (June 2026); the current reading is higher than 94% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 20.5× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/LQDA/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Liquidia Corporation P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/LQDA/metrics/pe-ratio">Liquidia Corporation (LQDA) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—

Period	P/E ratio	Change
Jun 2026	50.8×	(67.71%)
Mar 2026	157×	—
Dec 2025	0.0×	—
Sep 2025	0.0×	—
25 more quarters	Free account

Against its own ten years

Low 0.0× High 326×

Ten-year median 0.0×

Current reading's percentile 94

Company	P/E ratio
HIMS Hims & Hers Health, Inc. compare	n/m
RGC Regencell Bioscience Holdings Limited compare	n/m
HCM HUTCHMED (China) Limited Sponsored ADR compare	n/m
AMLX Amylyx Pharmaceuticals, Inc. compare	n/m
SUPN Indivior Pharmaceuticals Inc. compare	7.6×
PBH Prestige Consumer Healthcare Inc. compare	13.7×
LNTH Lantheus Holdings, Inc. compare	24.3×
LQDA Liquidia Corporation	28.5×
AMRX AMNEAL PHARMACEUTICALS, INC. compare	36.9×
Drug Manufacturers Specialty & Generic industry median	20.5×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Liquidia Corporation (LQDA) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on LQDA

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on LQDA

Stockrow Weekly